{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:23:16Z","timestamp":1740147796994,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12098-023-04913-1","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T07:02:37Z","timestamp":1699426957000},"page":"959-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Vascular Endothelial Growth Factor (Anti-VEGF) for the Treatment of Type I ROP"],"prefix":"10.1007","volume":"91","author":[{"given":"Rama Krushna","family":"Gudu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmath Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravati","family":"Jena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-8747","authenticated-orcid":false,"given":"Santosh Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"4913_CR1","first-page":"S80","volume":"53","author":"S Dutta","year":"2016","unstructured":"Dutta S, Raghuveer T, Vinekar A, et al. Can we stop the current epidemic of blindness from retinopathy of prematurity? Indian Pediatr. 2016;53:S80\u20134.","journal-title":"Indian Pediatr"},{"key":"4913_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajo.2020.05.025","volume":"218","author":"ME Hartnett","year":"2020","unstructured":"Hartnett ME. Retinopathy of prematurity: Evolving treatment with anti-vascular endothelial growth factor. Am J Ophthalmol. 2020;218:208\u201313.","journal-title":"Am J Ophthalmol"},{"key":"4913_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/PHMT.S391591","volume":"14","author":"MR Dogra","year":"2023","unstructured":"Dogra MR, Vinekar A. Role of anti-vascular endothelial growth factor (anti-VEGF) in the treatment of retinopathy of prematurity: A narrative review in the context of middle-income countries. Pediatric Health Med Ther. 2023;14:59\u201369.","journal-title":"Pediatric Health Med Ther"},{"key":"4913_CR4","unstructured":"Pjaver RK, Bilagi AP, Vinekar A, et al. Evidence based ROP guidelines in the NNF evidence based guidelines. 2010. p. 253\u201363. Available at: https:\/\/www.ontop-in.org\/ontop-pen\/Week-12-13\/ROP%20NNF%20Guidelines%20.pdf. Accessed on 25 May 2023."},{"key":"4913_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"4913_CR6","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1007\/s13312-016-0806-3","volume":"53","author":"D Chawla","year":"2016","unstructured":"Chawla D, Darlow BA. Anti-vascular endothelial growth factor preparations in the treatment of retinopathy of prematurity: Balancing risks and benefits. Indian Pediatr. 2016;53:S129\u201336.","journal-title":"Indian Pediatr"},{"key":"4913_CR7","first-page":"S123","volume":"53","author":"S Sivanandan","year":"2016","unstructured":"Sivanandan S, Chandra P, Deorari AK, Agarwal R. Retinopathy of prematurity: AIIMS, New Delhi experience. Indian Pediatr. 2016;53:S123\u20138.","journal-title":"Indian Pediatr"},{"key":"4913_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603\u201315.","journal-title":"N Engl J Med"},{"key":"4913_CR9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.4103\/ijo.IJO_200_21","volume":"69","author":"A Gangwe","year":"2021","unstructured":"Gangwe A, Agrawal D, Vinekar A, et al. Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society. Indian J Ophthalmol. 2021;69:2158\u201363.","journal-title":"Indian J Ophthalmol"},{"key":"4913_CR10","first-page":"CD009734","volume":"1","author":"MJ Sankar","year":"2018","unstructured":"Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018;1:CD009734.","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04913-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-023-04913-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04913-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T08:31:26Z","timestamp":1724401886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-023-04913-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4913"],"URL":"https:\/\/doi.org\/10.1007\/s12098-023-04913-1","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"type":"print","value":"0019-5456"},{"type":"electronic","value":"0973-7693"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}